Patent · US Active

Permselective membrane for treating vascular calcifications in chronic hemodialysis patients

US11103624B2 · kind B2 · utility

0Cited by

1References

20Claims

0Family size

Assignees

GAMBRO LUNDIA AB · SE
CHARITÉ—UNIVERSITÄTSMEDIZIN BERLIN · DE

Inventors

Markus Storr · Echterdingen, DE
Bernd Krause · Liederbach, DE
Ralf Schindler · Berlin, DE
Daniel Zickler · Berlin, DE
Bjoern Hegner · Berlin, DE

Key dates

Filing date	Apr 18, 2018
Grant date	Aug 31, 2021
Priority date	—
Expiry date	Jul 2, 2040

Classification

Technology area (CPC B)Performing Operations; Transporting
CPC primaryB01D2325/38
WIPO fieldChemical engineering
WIPO sectorChemistry

Abstract

The present disclosure relates to a hemodialysis membrane for the treatment of vascular calcification in hemodialysis patients, especially in chronic hemodialysis patients. The present disclosure further relates to methods of treating vascular calcification in hemodialysis patients, wherein the hemodialysis membrane is characterized in that it comprises at least one hydrophobic polymer and at least one hydrophilic polymer and in that it has a MWRO of between 15 and 20 kD and a MWCO of between 170-320 kD or that the hemodialysis membrane comprises at least one hydrophobic polymer and at least one hydrophilic polymer and has a MWRO of between 8.5 kD and 14.0 kD and a MWCO of between 55 kD and 130 kD.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.